The company mission is to supply oligosaccharides and polysaccharides for biological applications targeting plant health, pharmacy, nutraceutics and cosmetics.
ELICITYL has two commercial offers:
OligoTech®: a Library of complex carbohydrates & glycoproducts
The OligoTech® offer gives business opportunities using the untapped variety of complex sugars in compliance with all regulation appliances.
Complex sugars for Plant health: ELICITYL commercialises PEL101GV®, a complex sugar extracted from biomass enhancing the natural vine resistance to spring frosts.
ELICITYL has an extensive skill in complex sugar manufacturing and valorisation. In particular, the OligoTech® offer is based on the know-how in extraction, purification and fine characterization of complex sugars and on unique industrial production means owned and controlled by ELICITYL. Elicityl’s supplying capabilities include sampling lines to scaled-up industrial processes enabling the delivery from the g to multi kg scale.
ELICITYL coordinates an industrial consortium program to create a bank of complex sugar with screening on antiviral activity (hepatitis C, influenza and dengue viruses). This R&D project (CARBINFEC) is supported by the world competitive cluster, Lyonbiopôle focused on infectious diseases.
746 avenue Ambroise Croizat
Phone : +33 (0)4 76 40 71 61
Fax : +33 (0)76 45 49 50
Elicityl - SA à conseil de surveillance.
n° Siret: 442 055 893. Code APE: 731Z.
Intra-communautaire: FR 844 420 558 930 0022